Our Work

NovoPedics, Inc., is developing an implantable medical device that restores mobility to patients suffering from severe meniscal knee injuries.

The company's first product, Meniscofix™, is a biodegradable polymer, fiber-reinforced scaffold for total meniscal replacement. It provides an innovative way to replace damaged meniscal tissue with a patented fiber-reinforced design similar to the native meniscus and can be attached to both soft tissue and bone, allowing it to be used in total meniscus replacement surgery.

In addition to functional mobility, Meniscofix™ may prevent the long-term development of arthritis that so often occurs as a result of meniscus knee surgery. Pre-clinical studies have shown strong results through one year post-implantation in large animal model such as sheep.

NovoPedics is finalizing these studies and performing additional in vivo proof of concept studies. The company has already developed a second generation scaffold device, which has proven to provide better support and repair capabilities than the first generation device.

Board Members

Charles J. Gatt, Jr. MD
FOUNDER

Michael G. Dunn, PhD
FOUNDER

James M. Golubieski
REPRESENTATIVE
Foundation Venture Capital Group

Vince Smeraglia, Esq.
RUTGERS OBSERVER

Officers

Charles J. Gatt, Jr. MD
PRESIDENT

Michael G. Dunn, PhD
SECRETARY & TREASURER